Founder & COOJon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Abivax stock climbed more than 30% after the French biotech released additional data from its late-stage trial of obefazimod, showing that cancer cases in the study were consistent with background rates expected in that patient population.
Stoke Therapeutics Inc. (NASDAQ:STOK) said it has completed enrollment of 162 patients in its Phase 3 EMPEROR study of zorevunersen, an investigational RNA medicine for Dravet syndrome.
Unicycive Therapeutics (NASDAQ:UNCY) said the U.S. Food and Drug Administration issued a Complete Response Letter for its resubmitted new drug application for oxylanthanum carbonate, a treatment for hyperphosphatemia in chronic kidney disease patients on dialysis.
Novocure (NASDAQ:NVCR) said its Optune Pax device has received CE Mark approval for treating adult patients with locally advanced pancreatic cancer of exocrine origin in combination with gemcitabine and nab-paclitaxel.
Magnachip Semiconductor (NYSE:MX) appointed Chae Lee as Chief Executive Officer, effective July 1, 2026, marking a leadership change after nearly 11 months under interim CEO Camillo Martino.
KuCoin is facing renewed scrutiny after blockchain investigator ZachXBT alleged the exchange sent legal warnings following claims that about US$250,000 stolen through an Atomic stealer attack on 18 August 2025 was routed through five alleged KuCoin deposit addresses.
Innovent Biologics and Lilly (NYSE:LLY) entered a commercialization agreement for Verzenios (abemaciclib) in mainland China, shifting commercial control to Innovent.
Bitcoin (CRYPTO:BTC) is attracting buying interest from sovereign wealth funds at current price levels, with MidChains Chief Executive Officer Basil Al Askari saying at least one state-owned investment fund has accumulated spot Bitcoin and another may follow in the coming weeks.
Neoen has commenced construction on a 215-megawatt battery system at its Culcairn solar farm in New South Wales.
Buxton Resources (ASX:BUX) completes the sale of its 49% Copper Wolf Project interest to an IGO (ASX:IGO) subsidiary for $5.9 million and US$168,000
